Latest news with #mobilehealth
Yahoo
5 days ago
- Business
- Yahoo
Health Net and Centene Corporation (CNC) Commit Over $7.2 Million to Boost Healthcare Access Through Mobile Clinics in California
Health Net and the Centene Corporation (NYSE:CNC)'s philanthropic arm, Centene Foundation, have announced a major $7.2 million investment to expand healthcare access for underserved Californians through a new fleet of mobile health clinics. The initiative, part of the Mobile Outreach for Value, Equity and Sustainability (MOVES) program, will deliver preventative care, screenings, health education, and social support directly to communities facing barriers such as limited transportation and lost wages from time off work. Local partners, including AltaMed, Community Medical Centers, Kaweah Health, and Vision y Compromiso, will deploy pop-up clinics and mobile medical vans at parks, community events, and other gathering spots, aiming to reach thousands who might otherwise go without care. A doctor exchanging files with a patient in a clinical setting, highlighting the company's commitment to rare diseases treatment. Leaders say these mobile clinics are more than vehicles; they are lifelines that bring compassionate, equitable care to where people live and gather, building trust and fostering long-term relationships between healthcare providers and the communities they serve. The grants also position recipient organizations as conveners, bringing together local partners to address a full spectrum of physical, behavioral, and social needs. This investment by Health Net and Centene Corporation (NYSE:CNC)'s Centene Foundation builds on their broader commitment, over $158 million in funding for community-based organizations since 2017, and reflects a long-term strategy to strengthen California's health infrastructure and improve outcomes statewide. While we acknowledge the potential of CNC to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CNC and that has 100x upside potential, check out our report about this READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Medscape
23-05-2025
- Health
- Medscape
Smartphone Monitoring Cuts BP Post-ED Discharge
In a study, patients who received a team-based intervention involving education and mobile health support in the emergency department (ED) had greater reduction in systolic blood pressure (SBP) at 6 months than those who received standard discharge care. METHODOLOGY: A randomized clinical trial enrolled 574 adult patients (mean age, 51.1 years) with elevated BP (between 140/90 mm Hg and 180/110 mm Hg) who visited an urban academic ED between February 2019 and March 2023. Participants were randomly assigned to receive either standard discharge instructions and a primary care referral (n = 285) or a multicomponent education and empowerment intervention (E2; n = 289), which included a brief consultation with a clinical pharmacist and a smartphone-connected BP monitor with behavior change text reminders. The primary outcome was a mean change in SBP at 6 months. Secondary outcomes included changes in SBP at 3 months and changes in diastolic BP (DBP) at both 3 and 6 months. TAKEAWAY: At 6 months, patients who received the E2 intervention had a greater reduction in SBP than those who received usual care (mean difference, 4.9 mm Hg; P = .02). = .02). The between-group differences in SBP at 3 months (4.2 mm Hg) and DBP at 6 months (2.3 mm Hg) were not statistically significant. At 6 months, 42.9% of participants in the E2 group and 36.9% in the usual care group achieved BP levels ≤ 140/90 mm Hg, but this difference was not significant ( P = .22). IN PRACTICE: "Results of the TOUCHED randomized clinical trial suggest that a multicomponent Education and Empowerment (E2) intervention initiated in the ED may present a viable and effective strategy for reducing SBP in patients with elevated BP who are discharged from the ED," the authors wrote. SOURCE: The study was led by Heather Prendergast, MD, MPH, MS, Department of Emergency Medicine, University of Illinois Chicago. It was published online on April 23, 2025, in JAMA Cardiology . LIMITATIONS: Recruitment and follow-up occurred during the COVID-19 pandemic, which could have reduced participation and introduced selection bias. The single-center design limited generalizability. Long-term cardiovascular outcomes were not assessed. DISCLOSURES: The study was funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health. Several authors reported receiving grants from the National Institutes of Health and/or National Heart, Lung, and Blood Institute during the conduct of the study.
Medscape
20-05-2025
- Health
- Medscape
Mobile Health Tech May Enhance Heart Failure Care
Compared with usual care, the use of a mobile health technology that integrates telemonitoring and teleintervention during the vulnerable post-discharge period led to a reduction in the risk for new fatal and non-fatal cardiovascular events in patients recently hospitalised for heart failure (HF) decompensation. METHODOLOGY: Researchers conducted a randomised, phase 3, multicentre trial in Spain to assess the efficacy of a non-invasive mobile health service in post-discharge HF care. They included 506 adult patients (mean age, 73 years; 41% women) hospitalised for HF decompensation who were either recently discharged (within the past 30 days) or in the process of discharge planning. After discharge, patients were randomly assigned to receive either mobile health service comprising telemonitoring and preplanned structured healthcare follow-up via videoconference (n = 255) or usual care involving face-to-face visits (n = 251) between May 2018 and April 2022. Usual care followed the HF care framework of each centre and included a nurse-led educational programme on daily monitoring of biomedical data. The mobile health group received care on the basis of their daily biometric data, reported through a smartphone app connected to medical devices. The primary outcome was a composite of cardiovascular death or worsening HF events during the follow-up duration of 6 months. TAKEAWAY: Participants in the mobile health group had a 65% lower risk for the first event of the composite outcome — cardiovascular death or worsening HF events — than those in the usual care group (hazard ratio, 0.35; P < .0001). < .0001). The risk for a first event of worsening HF was 70% lower ( P < .0001) and that of cardiovascular death was 54% lower ( P = .047) in participants allotted to the mobile health group. < .0001) and that of cardiovascular death was 54% lower ( = .047) in participants allotted to the mobile health group. Compared with the usual care group, the mobile health group had a lower risk for non-fatal events and fewer occurrences of all-cause mortality and cardiovascular hospitalisations and showed improvements in self-care and quality of life. No spontaneously reported harms were reported in either of the groups. IN PRACTICE: "Integration of an eHealth [electronic health]-based solution into usual health-care systems and provision of a user-friendly interface for patients to promote adherence and persistence are two key aspects that likely contributed to the efficacy of mHealth [mobile health] in this trial," the authors wrote. SOURCE: This study was led by Sergi Yun, MD, and Josep Comín-Colet, PhD, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Barcelona, Spain. It was published online on May 14, 2025, in The Lancet Digital Health . LIMITATIONS: Data related to ethnicity of the patients were not recorded. The protocol allowed for local variations in standard care at each centre, which may have contributed to differences in data. DISCLOSURES: This trial received an unrestricted grant from Novartis. The authors declared having no competing interests.
